HRT Financial’s Aimmune Therapeutics AIMT Stock Holding History

HRT Financial’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-48,966	Closed	-$1.69M	–	2821
2020 Q3	$1.69M	Buy	+48,966	New	+$1.04M	0.05%	305

HRT Financial's AIMT Position: Q4 2020 in Review

HRT Financial sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 48,966 shares — an estimated $1.69M sold.

HRT Financial first reported a position in AIMT in Q3 2020 and held it in 1 quarter. The position peaked at $1.69M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

HRT Financial reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
HRT Financial sold 48,966 Aimmune Therapeutics shares in Q4 2020, an estimated $1.69M.
HRT Financial first reported a position in Aimmune Therapeutics in Q3 2020 and held it in 1 quarter.
HRT Financial's Aimmune Therapeutics position peaked at $1.69M in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on HRT Financial's 13F filing for Q4 2020, filed 16 Feb 2021.